[Effect of antirheumatic agents on the autoimmune reaction in vitro].
D000632:Aminopyrine / Q000008:administration & dosage*; D000937:Antigen-Antibody Reactions; D001241:Aspirin / Q000008:administration & dosage*; D001327:Autoimmune Diseases; D002254:Carbonates / Q000008:administration & dosage*; D003864:Depression, Chemical; D006801:Humans; D007109:Immunity / Q000187:drug effects*; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000494:pharmacology; D010653:Phenylbutazone / Q000008:administration & dosage*; D012216:Rheumatic Diseases / Q000276:immunology; D012964:Sodium / Q000008:administration & dosage*; D012980:Sodium Salicylate / Q000008:administration & dosage*; D013424:Sulfanilamides / Q000008:administration & dosage*
D002254:Carbonates; D007166:Immunosuppressive Agents; D013424:Sulfanilamides; D000632:Aminopyrine; D012964:Sodium; D010653:Phenylbutazone; D001241:Aspirin; D012980:Sodium Salicylate
Vliianie antirevmaticheskikh preparatov na autoimmunuiu reaktsiiu in vitro.